Erratum: Expression of concern: Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma(PLoS ONE (2013) 8:6 (e64976) DOI: 10.1371/journal.pone.0064976);Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zhen, Yan ^a   Ye, Yanfen ^a   Yu, Xiaoli ^a   Mai, Chunping ^a   Zhou, Ying ^a   Chen, Yan ^a   Yang, Huiling ^c   Lyu, Xiaoming ^a   Song, Ye ^a   Wu, Qiangyun ^a   Fu, Qiaofen ^a   Zhao, Mengyang ^a   Hua, Shengni ^a   Wang, Hao ^a   Liu, Zhen ^a,b   Zhang, Yajie ^a,b   Fang, Weiyi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN DEPENDENT KINASE 4; FOCAL ADHESION KINASE 1; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P15; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN; CTGF PROTEIN, HUMAN; CYCLINE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; DISTANT METASTASIS; DNA METHYLATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; CELL CLONE; CELL MOTION; CELL PROLIFERATION; DISEASE COURSE; EPITHELIUM; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; NASOPHARYNX; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CLONE CELLS; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NEOPLASM INVASIVENESS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROMOTER REGIONS, GENETIC; S PHASE; SIGNAL TRANSDUCTION;

EID: 84878635691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0231520     Document Type: Erratum

References (31)

1. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, et al. (2011) Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 38: 1741-1747.
2. Chu CY, Chang CC, Prakash E, Kuo ML, (2008) Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 15: 675-685.
3. Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, et al. (2009) Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9: 291.
4. Liu L, Li Z, Feng G, You W, Li J, (2007) Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C,-D and associated with shorter survival in gastric cancer. Pathol Int 57: 712-718.
5. Chen PP, Li WJ, Wang Y, Zhao S, Li DY, et al. (2007) Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2: e534.
6. Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, et al. (2009) The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 69: 775-784.
7. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, et al. (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895.
8. Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, et al. (2011) Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo. Chin Med J (Engl) 124: 3794-3799.
9. Croci S, Landuzzi L, Astolfi A, Nicoletti G, Rosolen A, et al. (2004) Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 64: 1730-1736.
10. Barbolina MV, Adley BP, Kelly DL, Shepard J, Fought AJ, et al. (2009) Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. Int J Cancer 125: 816-825.
11. Chuang JY, Yang WY, Lai CH, Lin CD, Tsai MH, et al. (2011) CTGF inhibits cell motility and COX-2 expression in oral cancer cells. Int Immunopharmacol 11: 948-954.
12. Fang W, Li X, Jiang Q, Liu Z, Yang H, et al. (2008) Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 6: 32.
13. Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, et al. (2010) Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98.Cell Death. Dis (1) (): e85.
14. Liu Z, Luo W, Zhou Y, Zhen Y, Yang H, et al. (2011) Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma. PLoS One. 6: e27887.
15. Wang S, Fang W, (2011) Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma. Histopathology. 58: 217-224.
16. Liu Z, Chen J, Luo W, Yang H, Wu A, et al. (2012) Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai) 44: 503-512.
17. Koga Y, Pelizzola M, Cheng E, Krauthammer M, Sznol M, et al. (2009) Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 19: 1462-1470.
18. Braig S, Wallner S, Junglas B, Fuchshofer R, Bosserhoff AK, (2011) CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Br J Cancer 105: 231-238.
19. Cui L, Zhang Q, Mao Z, Chen J, Wang X, et al. (2011) CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumour Biol 32: 721-728.
20. Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, et al. (2010) Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol 176: 939-951.
21. Jiang CG, Lv L, Liu FR, Wang ZN, Liu FN, et al. (2011) Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination. Mol Cancer 10: 122.
22. Wong YF, Cheung TH, Tsao GS, Lo KW, Yim SF, et al. (2006) Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 118: 2461-2469.
23. Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, et al. (2012) Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. Oncogene 31: 2401-2411.
24. Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, et al. (2007) Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res 67: 7095-7105.
25. Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, et al. (2004) Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst 96: 364-375.
26. Ma B, Sen T, Asnaghi L, Valapala M, Yang F, et al. (2011) βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axis.Cell Death Dis. 2: e217.
27. Jackson TC, Verrier JD, Kochanek PM, (2013) Anthraquinone-2-sulfonic acid (AQ2S) is a novel neurotherapeutic agent. Cell Death Dis. 4: e451.
28. Wang G, Wang F, Ding W, Wang J, Jing R, et al. (2013) APRIL induces tumorigenesis and metastasis of colorectal cancer cells via activation of the PI3K/Akt pathway. PLoS One. 8: e55298.
29. Wang H, Quah SY, Dong JM, Manser E, Tang JP, et al. (2007) PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 67: 2922-2926.
30. Cheng JC, Auersperg N, Leung PC, (2012) EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?. PLoS One. 7: e34071.
31. Jang JY, Jeon YK, Kim CW, (2010) Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 10: 391.